based on our inclusion and exclusion criteria. The correlation between body mass index and ideal weight gain was analyzed using Pearson test.
Randwick, the 3 Royal Hospital for Women
Background: Following the Parenteral Nutrition consensus, a policy was introduced in a tertiary neonatal intensive care unit to do regular plasma triglycerides and titrate parenteral lipid intakes to maintain plasma triglycerides ?2.8 mmol/L.
Method: A Quality improvement audit was conducted in infants 23-28 weeks gestation admitted to our facility between July 2012 and June 2016. Lipid emulsions were commenced at 1 g/kg/day along with starter Aminoacid/Dextrose immediately after birth and increased by 1 g/kg/day every 24 hours to a maximum of 3 g/kg/day. Plasma triglyceride levels were measured every 24 hours until after reaching 3 g/kg/day and then weekly if remained on lipid emulsion. If triglyceride level is >2.8 mmol/ L, lipid dosage was titrated. Main outcome measures were: (1) compliance to the policy, (2) incidence of hypertriglyceridaemia (HT, plasma triglycerides > 2.8 mmol/L) and (3) association of HT with mortality and major morbidities.
Results: There were 195 eligible infants and the compliance to triglyceride monitoring policy was 89.2%. HT was noted in 19.5% (32.5% in 23-25 wks and 16.1% in 26-28 wks); Nine (4.6%) developed severe HT (>5.5 mmol/L) and 10 (5.1%) had more than 1 episode. HT group was associated with significantly higher mortality (OR 3.49; 95% CI 1.13-10.76) and severe ROP (OR 4.06; 95% CI 1.73-9.59). HT was not an independent risk factor for these outcomes after adjusted for gestation and birthweight percentiles.
Conclusions: HT is common particularly in infants 23-25 week gestation receiving parenteral lipid emulsion. Regular monitoring and titration of lipid intake reduced the adverse influence of HT. Method: We conducted a quality improvement audit to determine the incidence of BUN concentrations <3.2 mmol/L in the first 12 weeks of life among 23-28 weeks gestation infants admitted to our tertiary neonatal facility between July 2012 and June 2016. We routinely administer Aminoacid (AA)/Dextrose and lipid emulsions immediately after birth, providing 2 g/kg/day of intravenous AA on day 1 with gradual increase over the next 5 days to 4 g/kg/day. Enteral protein intake is targeted up to 4.5 g/kg/day using cow's milk based fortifier incrementally added to maternal expressed breast milk (EBM) if tolerated or preterm formulas if inadequate EBM.
TRENDS IN BLOOD
Results: Among 195 studied infants (mean gestation 26.6 wks; birthweight 970.8 g), the proportion of infants with BUN < 3.2 mmol/L were low in the first 2 weeks of life but increased rapidly to 80% by the 5 th week and remained high during hospital stay.
24 hr Wk1 Wk2 Wk3 Wk4 Wk5 Wk6 Wk7 Wk8 Wk9 Wk10 Wk11 Wk12 % inpatients 3% 3% 30% 51% 63% 78% 79% 86% 84% 80% 80% 78% 79%
Feed tolerance was a common limiting factor in protein intake enhancement encountered.
Conclusions: There is a very high incidence of inadequate protein intake in infants 23-28 weeks gestation. A better strategy for improved protein intake needs to be explored. A set of standardised observation charts suitable for newborns aged '32 weeks-Term (corrected)' and 'Term (corrected) to 28 days' were designed and piloted in 12 Victorian hospitals from August to November 2016. Two types of charts were developed: one for the BirthSuite/Postnatal (BSPN) areas and another for 'Neonates' (up to 28 days) in special care nurseries, emergency departments and paediatric wards. As part of a multimethod evaluation this report examines user satisfaction and determines chart suitability for recording clinical observations and communicating clinical care.
Methods: Focus groups were conducted using a 'Claims, Concerns and Issues' framework to facilitate group discussion and determine what was working well and what could be improved. Together the participants established key themes and identified appropriate ways forward.
Results: 20 focus groups were conducted with 172 clinicians across all pilot sites in November. Commonly identified Claims included; the ease of identifying trends, the use of colours to identify abnormal parameters and being able to view all the observations on the one page. For the BSPN chart the incorporation of the Newborn Risk Assessment section was viewed positively. Key Concerns related to; the increments for recording temperature, documenting desaturation/bradycardic episodes and lack of ability to interpret observations in relation to feeding. Duplication of documentation and compliance with escalation processes were additional concerns.
Conclusion: User feedback via focus groups has been a crucial aspect of the evaluation. Findings will inform changes to chart design, ongoing education and implementation strategies in preparation for a planned state-wide roll out in 2017.
CONGENITAL CYTOMEGALOVIRUS RISK FACTORS, MORBIDITY AND HOSPITAL ADMISSIONS, NSW 2001-2011
Hayley Smithers-Sheedy 1* , Gulam Khandaker 2 , Camille Raynes- Results: cCMV cases n = 121, were more frequently born preterm (M 34.5 weeks SD 5.5 vs 38.9 weeks SD 2.0, p < 0.0001), with low birth weights (M 2264 g SD 1067 vs 3381 g SD 590 p < 0.0001) and APGARs <7 at 5 mins (18.8% vs 1.97%, p < 0.0001) than controls (n = 2686). Adverse sequelae including CP, epilepsy, hearing impairment, intellectual impairment and vision impairment were over-represented amongst cCMV cases (all p < 0.0001). In addition to the significant morbidity there were 10 deaths of children with cCMV during this period. cCMV hospital admissions (n = 1178) were significantly longer in median length of hospital stay overall and there were higher mean admission cost weights for both neonatal care (16.5 vs 0.96, p < 0.0001) and acute care (2.84 vs 0.97, p < 0.0001) compared with controls Conclusion: There is a high burden of neurological comorbidities and longer, more expensive hospital admissions in children with cCMV compared to controls. Cost-effectiveness analyses for newborn screening and prevention strategies to reduce infection and adverse outcomes are warranted.
